A
Adam Johnson
Researcher at Centers for Disease Control and Prevention
Publications - 3
Citations - 1218
Adam Johnson is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Neuraminidase & Virus. The author has an hindex of 2, co-authored 2 publications receiving 1016 citations.
Papers
More filters
Journal ArticleDOI
New world bats harbor diverse influenza A viruses.
Suxiang Tong,Xueyong Zhu,Yan Li,Mang Shi,Jing Zhang,Melissa Bourgeois,Hua Yang,Xianfeng Chen,Sergio Recuenco,Jorge Gomez,Li-Mei Chen,Adam Johnson,Ying Tao,C. Dreyfus,Wenli Yu,Ryan McBride,Paul J. Carney,Amy T. Gilbert,Jessie Chang,Zhu Guo,Charles T. Davis,James C. Paulson,James Stevens,Charles E. Rupprecht,Charles E. Rupprecht,Edward C. Holmes,Edward C. Holmes,Ian A. Wilson,Ruben O. Donis +28 more
TL;DR: Using consensus degenerate RT-PCR, a novel influenza A virus is identified in a flat-faced fruit bat from Peru, indicating that bats constitute a potentially important and likely ancient reservoir for a diverse pool of influenza viruses.
Journal ArticleDOI
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
Houriiyah Tegally,James Emmanuel San,Matthew Cotten,Bryan Fulbert Nkengfack Tegomoh,Gerald Mboowa,Darren P. Martin,Carla Baxter,Monika Moir,Arnold W. Lambisia,Abdourahmane Diallo,Daniel G. Amoako,Moussa Moïse Diagne,Awoke Sisay,Abdel-Rahman N. Zekri,Amal Barakat,Aïssatou Gueye,A. Sangare,A. Ouedraogo,A Sow,Abdelmageed Osman Musa,A Sesay,Adamou Lagare,Adedotun-Sulaiman Kemi,Arjan Abar,Adam Johnson,Adeola Fowotade,A. M. Olubusuyi,A Oluwapelumi,A. A. Amuri,A. Juru,Ahmed M. Ramadan,Ahmed Kandeil,Ahmed Mostafa,Ahmed Rebai,Abu Sayed,A. Kazeem,A. M. C. Balde,Alan Christoffels,Alexander J. Trotter,A. Campbell,A. Keita,Aminatou Kone,Anis Bouzid,Amal Souissi,Agweyu +44 more
TL;DR: There is an increase in the number of African countries able to sequence within their own borders, coupled with a decrease in sequencing turnaround time, which underscores the heterogeneous nature of the pandemic.
Journal ArticleDOI
Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.
Ruben O. Donis,i-Mei Chen,C. Todd Davis,Angie Foust,M. Jaber Hossain,Adam Johnson,Alexander Klimov,Rosette Loughlin,Xiyan Xu,Theodore F. Tsai,Theodore F. Tsai,Simone Blayer,Simone Blayer,Heidi Trusheim,Heidi Trusheim,Tony Colegate,Tony Colegate,John Fox,John Fox,Beverly Taylor,Beverly Taylor,Althaf I. Hussain,Althaf I. Hussain,Ian G. Barr,Chantal Baas,Jaap Louwerens,Ed Geuns,Min-Shi Lee,Min-Shi Lee,Odewijk Venhuizen,Odewijk Venhuizen,Elisabeth Neumeier,Thedi Ziegler,Thedi Ziegler +33 more
TL;DR: The antigenic stability of viruses isolated and propagated in cell lines qualified for influenza vaccine manufacture were tested and results indicate that influenza viruses isolated in vaccine certified cell lines may well qualify for use in vaccine production.